Cytokeratin markers CK7 and CK20 aid in discriminating primary and metastatic gastric tumors, with CK7 prevalent in breast, lung, and ovarian adenocarcinomas, while CK20 shows heightened expression in stomach, colon, and pancreas (9). The gene discussed is KRT7; the disease is ovarian adenocarcinoma.